Fig. 8From: Isolation and characterization of two canine melanoma cell lines: new models for comparative oncologyvHuman (A375 and Sk-Mel28) and canine melanoma cell lines (Ocr_OCMM2X and Ocr_OCMM1X) sensitivity to Dacarbazine (a), Vemurafenib (b) and LY294002 (c). Dose-response curves were generated after 72 h treatment with each compound and IC50 ± SEM values were determined using GraphPad Prism® software (n = 6)Back to article page